Vaccine News and Research

Latest Vaccine News and Research

Study creates a radical new view of how immune cells recognize threats

Researchers have created a radical new view of how immune cells recognise threats such as viruses. The discovery could be used to design better vaccines and to gain a deeper insight into autoimmune diseases and allergies.

10 Mar 2023

COVID-19 vaccination may reduce the risk of thrombosis in hospitalized patients

A study published in the British Journal of Hematology describes that coronavirus disease 2019 (COVID-19) vaccines are effective in reducing thrombotic events and preventing disease severity in individuals with breakthrough severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

10 Mar 2023

How effective are monovalent mRNA COVID-19 vaccine booster doses against Omicron-associated severe outcomes among adults?

Researchers from Canada investigated the efficacy of booster doses of the monovalent mRNA COVID-19 vaccine in preventing hospitalization and death during the dominance of the SARS-CoV-2 Omicron variant.

10 Mar 2023

Exploring COVID-19 immunization speed and timing in Africa

A new BMC Medicine study retrospectively analyzed the impact of COVID-19 vaccination timing and speed on the virus transmission in 27 African countries, based on a combined epidemiological and economic modeling approach. The authors aimed to inform future decisions about vaccine roll-out and investment.

10 Mar 2023

Montana considers new wave of legislation to loosen vaccination rules

When Deb Horning's youngest daughter was 5, she got her measles, mumps, and rubella shot like many other kindergartners. But unlike many other moms, Horning had to stay away from her daughter for a week after the shot.

10 Mar 2023

Electronic messaging tactics increase flu vaccination rates, Danish study shows

Approximately one billion people are infected with influenza around the world each year, with more than half a million deaths estimated to result from the disease.

9 Mar 2023

Investigating the impact of COVID-19 vaccinations in immunocompromised adult patients

In a recent study posted to the medRxiv* preprint server, researchers assessed the impact of third and fourth coronavirus disease 2019 (COVID-19) vaccination doses on immunity against COVID-19 among immunocompromised adult patients.

9 Mar 2023

Researchers develop a 100%-effective mRNA vaccine for deadly bacteria

For the first time in the world: a team of researchers from Tel Aviv University and the Israel Institute for Biological Research have developed an mRNA-based vaccine that is 100% effective against a type of bacteria that is lethal to humans.

9 Mar 2023

ACE2: its diverse functions, relationship with SARS-CoV-2, and the implications for COVID-19 disease sequelae

Researchers assessed the role of ACE2 in the COVID-19 pandemic.

9 Mar 2023

Evaluating SARS-CoV-2 bivalent booster vaccine against severe COVID-19 outcomes

In a recent study posted to the medRxiv* preprint server, researchers assessed the effectiveness of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) bivalent booster vaccine against severe SARS-CoV-2 infection outcomes.

9 Mar 2023

100% vaccination rate could have prevented half of COVID-19 deaths in the U.S.

Scientists in the United States have conducted a simulation study to estimate the number of coronavirus disease 2019 (COVID-19) deaths that could have been prevented by increasing vaccination coverage in the country.

7 Mar 2023

Symptomatic COVID-19 is associated with deficits in task-related cognitive function and psychiatric symptoms

Researchers conducted a prospective population survey, functional brain imaging, and a cognitive task performance test to determine whether a history of symptomatic coronavirus disease 2019 (COVID-19) was associated with psychiatric and neurocognitive symptoms.

7 Mar 2023

Effectiveness of monovalent COVID-19 mRNA booster vaccination vs. two-dose primary series during Omicron variant circulation

Researchers estimated the immune protection conferred by monovalent-type COVID-19 mRNA booster doses vs. two-dose prime vaccination series during SARS-CoV-2 Omicron variant predominance in community settings.

7 Mar 2023

Decades of substantial U.S. Government investment in mRNA technology paved way for COVID-19 vaccines

Researchers explore the United States public funding for the development of COVID-19 mRNA vaccines.

6 Mar 2023

Antibody levels from prime COVID-19 mRNA vaccine influences the efficacy of booster doses

Researchers evaluate the response of pre-existing immunity to booster doses of mRNA COVID-19 vaccines.

6 Mar 2023

IgG4 serum levels do not show elevation in post-COVID syndrome

In a recent study posted to bioRxiv* preprint server, researchers in Germany assessed the differences in antigen-specific immunoglobulin G (IgG) subtypes between post-COVID syndrome (PCS) patients and convalescent controls.

6 Mar 2023

How does chronic HBV infection affect flu and COVID-19 vaccine responses?

The influenza season marks the beginning of a time of illness, sometimes serious or even fatal, in much of the world. For this reason, flu shots are recommended, especially for individuals with underlying diseases such as chronic hepatitis B (CHB) infection, since they are at higher risk for adverse outcomes.

6 Mar 2023

Clinical trial shows safety and immunogenicity of temperature-stable experimental TB vaccine

A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both antibodies and responses from the cellular arm of the immune system.

6 Mar 2023

Study: More than 25% of parents misrepresented their children's COVID-19 status

More than 25% of parents surveyed report that they were less than truthful about their children's COVID-19 status or that they didn't follow the disease's preventive guidelines during the pandemic for their offspring, according to a nationwide study led in part by University of Utah scientists.

6 Mar 2023

Trial emulation shows the effectiveness of the COVID-19 vaccine in improving long COVID symptoms

In a recent article published in the BMJ, researchers evaluated the effect of coronavirus disease 2019 (COVID-19) vaccines on patients with long COVID.

6 Mar 2023

Previous
1
...
84
85
86
87
88
89
90
...
1122
Next

Vaccine News and Research

Latest Vaccine News and Research

Study creates a radical new view of how immune cells recognize threats

COVID-19 vaccination may reduce the risk of thrombosis in hospitalized patients

How effective are monovalent mRNA COVID-19 vaccine booster doses against Omicron-associated severe outcomes among adults?

Exploring COVID-19 immunization speed and timing in Africa

Montana considers new wave of legislation to loosen vaccination rules

Electronic messaging tactics increase flu vaccination rates, Danish study shows

Investigating the impact of COVID-19 vaccinations in immunocompromised adult patients

Researchers develop a 100%-effective mRNA vaccine for deadly bacteria

ACE2: its diverse functions, relationship with SARS-CoV-2, and the implications for COVID-19 disease sequelae

Evaluating SARS-CoV-2 bivalent booster vaccine against severe COVID-19 outcomes

100% vaccination rate could have prevented half of COVID-19 deaths in the U.S.

Symptomatic COVID-19 is associated with deficits in task-related cognitive function and psychiatric symptoms

Effectiveness of monovalent COVID-19 mRNA booster vaccination vs. two-dose primary series during Omicron variant circulation

Decades of substantial U.S. Government investment in mRNA technology paved way for COVID-19 vaccines

Antibody levels from prime COVID-19 mRNA vaccine influences the efficacy of booster doses

IgG4 serum levels do not show elevation in post-COVID syndrome

How does chronic HBV infection affect flu and COVID-19 vaccine responses?

Clinical trial shows safety and immunogenicity of temperature-stable experimental TB vaccine

Study: More than 25% of parents misrepresented their children's COVID-19 status

Trial emulation shows the effectiveness of the COVID-19 vaccine in improving long COVID symptoms

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Vaccine News and Research

Latest Vaccine News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in